Skip to Main Content

Guardant in the News

July 13, 2023

Unlocking the secrets of cancer in our blood: A founder’s perspective

A Q&A with Helmy Eltoukhy, Ph.D., co-founder, chairman and co-chief executive officer of Guardant Health

June 21, 2023

Can a Blood Test Screen for Colon Cancer? Guardant Health Chief Medical Officer Shares Promising Update

Currently, there’s a huge push in the cancer community to develop blood tests that can screen for different types of the disease. A company called Guardant Health is working on one of these tools, a test called “Shield” that can screen blood for signs of early-stage colon cancer.

June 19, 2023

EUCOPE launches the European Coalition for Access to Comprehensive Genomic Profiling (ECGP)

EUCOPE, along with Exact Sciences, Guardant Health, Illumina, MSD and Novartis, launch the European Coalition for Access to Comprehensive Genomic Profiling (ECGP)

April 14, 2023

Patients Don’t Want Colonoscopies – Let’s Give Them Something Better

The life-saving potential of alternative screening methods for colorectal cancer

March 30, 2023

Blood tests may spare cancer patients chemo

A blood test which can detect traces of cancer cells could spare thousands of patients unnecessary chemotherapy every year.